Cite
Design and synthesis of a novel series of 4-heteroarylamino-1′-azaspiro[oxazole-5,3′-bicyclo[2.2.2]octanes as α7 nicotinic receptor agonists 2. Development of 4-heteroaryl SAR.
MLA
Iwuagwu, Christiana, et al. “Design and Synthesis of a Novel Series of 4-Heteroarylamino-1′-Azaspiro[Oxazole-5,3′-Bicyclo[2.2.2]Octanes as Α7 Nicotinic Receptor Agonists 2. Development of 4-Heteroaryl SAR.” Bioorganic & Medicinal Chemistry Letters, vol. 27, no. 5, Mar. 2017, pp. 1261–66. EBSCOhost, https://doi.org/10.1016/j.bmcl.2017.01.058.
APA
Iwuagwu, C., King, D., McDonald, I. M., Cook, J., Zusi, F. C., Hill, M. D., Mate, R. A., Fang, H., Knox, R., Gallagher, L., Post-Munson Amy Easton, D., Miller, R., Benitex, Y., Siuciak, J., Lodge, N., Zaczek, R., Morgan, D., Bristow, L., Macor, J. E., & Olson, R. E. (2017). Design and synthesis of a novel series of 4-heteroarylamino-1′-azaspiro[oxazole-5,3′-bicyclo[2.2.2]octanes as α7 nicotinic receptor agonists 2. Development of 4-heteroaryl SAR. Bioorganic & Medicinal Chemistry Letters, 27(5), 1261–1266. https://doi.org/10.1016/j.bmcl.2017.01.058
Chicago
Iwuagwu, Christiana, Dalton King, Ivar M. McDonald, James Cook, F. Christopher Zusi, Matthew D. Hill, Robert A. Mate, et al. 2017. “Design and Synthesis of a Novel Series of 4-Heteroarylamino-1′-Azaspiro[Oxazole-5,3′-Bicyclo[2.2.2]Octanes as Α7 Nicotinic Receptor Agonists 2. Development of 4-Heteroaryl SAR.” Bioorganic & Medicinal Chemistry Letters 27 (5): 1261–66. doi:10.1016/j.bmcl.2017.01.058.